Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study

Inclusion Criteria: * Diagnosis of a pigment epithelial tear secondary to age-related macular degeneration * Written informed consent Exclusion Criteria: * Time of diagnosis more than 6 months before study recruitment * Ocular surgery of the study eye within 1 month before study recruitment * Extensive subretinal fibrosis or retinal atrophy of the study eye * Significant opacification of optical media of the study eye * Uncontrolled glaucoma of the study eye * Active ocular inflammation of the study eye * Best-corrected visual acuity of the contralateral eye below 20/200 * Concurrent ocular or systemic therapy with other vascular endothelial growth factor (VEGF)-inhibitory drugs